Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label ...

For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss.

(HealthDay News) — From 1999 to 2020, obesity-related cancer mortality increased significantly, according to a study presented at ENDO 2025, the annual meeting of the Endocrine Society, held from July ...

Sweetener consumption and genetic predisposition are independently associated with the risk for central precocious puberty (CPP), according to a study presented at ENDO 2025, the annual meeting of the ...

Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the best low priced pharma stocks to buy now. On July 13, Amylyx ...

A development called Sea Country, near the neighborhood that was recently ordered to evacuate during a wildfire, is close to ...

Research from ENDO 2025 reveals that GLP-1 anti-obesity medications not only aid in weight loss but also improve testosterone ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

Intermittent energy restriction, time-restricted eating and continuous energy restriction can all improve blood sugar levels ...

GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...

Pregnant Elsie Hewitt teased her "weird chaotic month" with Pete Davidson prior to announcing their baby news.

OMS1620 is advancing through IND-enabling studies for diseases associated with ACTH excess, including congenital adrenal ...